Uta Griesenbach | Professor, Molecular Medicine, National Heart And Lung Institute; President, British Society For Gene And Cell Therapy;
Imperiai College London

Uta Griesenbach, Professor, Molecular Medicine, National Heart And Lung Institute; President, British Society For Gene And Cell Therapy;, Imperiai College London

Uta Griesenbach is a Professor in Molecular Medicine at the National Heart and Lung Institute, Imperial College London and the President of the British Society for Gene and Cell Therapy (www.bsgct.org/). Uta‘s reserach interests are related to the development of gene therapy-based treatments for cystic fibrosis and other inflammatory lung diseases and include vector and biomarker development, toxicology and safety as well as GMP-vector production. Uta is Co-Investigator on several gene therapy trials, including a recently completed non-viral Phase IIb study. Uta is a Strategy Group Member of the UK Cystic Fibrosis Gene Therapy Consortium (www.cfgenetherapy.org.uk/) and is the Gene Therapy advisor (GTAC) on the West London National Research Ethics Comittee. In addition, Uta is interested in teaching and work-force development. She is Deputy-director for post-graduate reserach at the National Heart and Lung Institute and Programme director for the MSc in Genes, Drugs and Stem cells-Novel Therapies at Imperial College.

Appearances:



Conference Day 2 - Wednesday 1st April 2020 @ 11:20

Gene therapy for rare respiratory diseases

last published: 05/Dec/19 09:46 GMT

back to speakers